Breast/ovarian cancer
1 – 10 of 42
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
Martin de la Fuente, Laura LU ; Westbom-Fremer, Sofia LU
; Arildsen, Nicolai Skovbjerg
LU
; Hartman, Linda
LU
; Malander, Susanne
LU
; Kannisto, Päivi
LU
; Måsbäck, Anna
LU
and Hedenfalk, Ingrid
LU
(2020)
In Virchows Archiv : an international journal of pathology
477(1).
p.83-91
Mark
-
Analysis of fusion transcripts indicates widespread deregulation of snoRNAs and their host genes in breast cancer
Persson, Helena LU
; Søkilde, Rolf
LU
; Häkkinen, Jari
LU
; Vallon-Christersson, Johan
LU
; Mitelman, Felix
LU
; Borg, Åke
LU
; Höglund, Mattias
LU
and Rovira, Carlos
LU
(2020)
In International Journal of Cancer
146(12).
p.3343-3353
Mark
-
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
Bååth, Maria LU ; Westbom-Fremer, Sofia LU
; Martin de la Fuente, Laura
LU
; Ebbesson, Anna
LU
; Davis, Juliette
; Malander, Susanne
LU
; Måsbäck, Anna
LU
; Kannisto, Päivi
LU
and Hedenfalk, Ingrid
LU
(2020)
In Molecular and Cellular Oncology
7(6).
Mark
-
The mutational landscape of the SCAN‐B real‐world primary breast cancer transcriptome
Brueffer, Christian LU
; Gladchuk, Sergii
LU
; Winter, Christof
LU
; Vallon-Christersson, Johan
LU
; Hegardt, Cecilia
LU
; Häkkinen, Jari
LU
; George, Anthony
LU
; Chen, Yilun
LU
; Ehinger, Anna
LU
and Larsson, Christer
LU
, et al.
(2020)
In EMBO Molecular Medicine
12(10).
Mark
-
Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer
Larsson, Christer LU ; Ehinger, Anna LU
; Winslow, Sofia
LU
; Leandersson, Karin
LU
; Klintman, Marie
LU
; Dahl, Ludvig
; Vallon-christersson, Johan
LU
; Häkkinen, Jari
LU
; Hegardt, Cecilia
LU
and Manjer, Jonas
LU
, et al.
(2020)
In npj Breast Cancer
6(1).
Mark
-
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
Glodzik, Dominik LU ; Bosch, Ana LU ; Hartman, Johan ; Aine, Mattias LU ; Vallon-Christersson, Johan LU
; Reuterswärd, Christel
LU
; Karlsson, Anna
LU
; Mitra, Shamik
LU
; Niméus, Emma
LU
and Holm, Karolina
LU
, et al.
(2020)
In Nature Communications
11(1).
Mark
-
Fine-tuning the metabolic rewiring and adaptation of translational machinery during an epithelial-mesenchymal transition in breast cancer cells
Fernández-Calero, Tamara ; Davyt, Marcos ; Perelmuter, Karen ; Chalar, Cora ; Bampi, Giovana ; Persson, Helena LU
; Tosar, Juan Pablo
; Hafstað, Völundur
LU
; Naya, Hugo
LU
and Rovira, Carlos
LU
, et al.
(2020)
In Cancer & metabolism
8.
p.8-8
Mark
-
Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq within the Sweden Cancerome Analysis Network: Breast Project (SCAN-B; NCT03430492).
Brueffer, Christian LU
; Gladchuk, Sergii
LU
; Winter, Christof
LU
; Vallon-christersson, Johan
LU
; Hegardt, Cecilia
LU
; Häkkinen, Jari
LU
; George, Anthony M
LU
; Chen, Yilun
LU
; Ehinger, Anna
LU
and Larsson, Christer
LU
, et al.
(2020)
In Journal of Clinical Oncology
38(15_suppl).
p.518-518
Mark
- CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
-
Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
Arildsen, Nicolai Skovbjerg LU and Hedenfalk, Ingrid LU
(2020)
In Oncotarget
11(40).
p.3660-3674
Mark